Loading...
XSHE000661
Market cap5.46bUSD
Dec 26, Last price  
100.20CNY
1D
-0.46%
1Q
0.30%
Jan 2017
-10.42%
Name

Changchun High & New Tech Industry Inc

Chart & Performance

D1W1MN
XSHE:000661 chart
P/E
8.79
P/S
2.74
EPS
11.39
Div Yield, %
1.02%
Shrs. gr., 5y
3.80%
Rev. gr., 5y
22.07%
Revenues
14.57b
+15.35%
366,492,643486,854,804580,454,579662,056,599804,155,5501,023,586,7911,165,962,4101,294,589,2941,761,187,2182,048,692,2812,262,304,4482,402,089,6412,897,439,8034,102,261,5785,374,994,7087,373,701,2668,576,600,70810,746,717,26212,627,188,96614,566,039,611
Net income
4.53b
+9.47%
7,314,81605,267,4186,502,65420,094,87573,154,66486,461,380109,548,646299,797,507283,898,219318,171,323384,479,499484,852,471661,948,7691,006,495,3591,775,009,1973,046,586,1453,757,472,9534,140,523,8034,532,483,532
CFO
5.11b
+80.85%
089,905,032118,249,773211,528,771163,798,123390,330,399348,989,743169,181,491407,944,688498,580,431279,752,231770,595,142308,073,522381,387,328884,066,5721,934,670,6851,110,989,8543,330,619,2252,826,408,3335,111,442,136
Dividend
Apr 18, 20244.5 CNY/sh

Profile

Changchun High-Tech Industries (Group) Inc., together with its subsidiaries, manufactures and sells biopharmaceuticals and proprietary Chinese medicines in China. It also engages in real estate development, property management, and real estate leasing services. The company was formerly known as Changchun High & New Technology Industry (Group) Inc. Changchun High-Tech Industries (Group) Inc. was founded in 1993 and is based in Changchun, China.
URL
http://ccht.jl.cn/
IPO date
Dec 18, 1996
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
14,566,040
15.35%
12,627,189
17.50%
10,746,717
25.30%
Cost of revenue
6,883,885
6,898,171
5,482,093
Unusual Expense (Income)
NOPBT
7,682,155
5,729,018
5,264,624
NOPBT Margin
52.74%
45.37%
48.99%
Operating Taxes
734,452
709,241
719,234
Tax Rate
9.56%
12.38%
13.66%
NOPAT
6,947,703
5,019,777
4,545,390
Net income
4,532,484
9.47%
4,140,524
10.19%
3,757,473
23.33%
Dividends
(404,666)
(321,798)
(323,776)
Dividend yield
0.68%
0.47%
0.29%
Proceeds from repurchase of equity
(218,563)
(87,773)
BB yield
0.37%
0.13%
Debt
Debt current
144,472
318,528
332,203
Long-term debt
712,476
1,174,349
1,250,596
Deferred revenue
120,543
135,124
151,709
Other long-term liabilities
120,716
307
253
Net debt
(7,912,092)
(5,323,870)
(5,405,988)
Cash flow
Cash from operating activities
5,111,442
2,826,408
3,330,619
CAPEX
(2,096,800)
Cash from investing activities
(2,289,724)
Cash from financing activities
(739,961)
806,810
FCF
4,912,092
2,369,058
2,366,209
Balance
Cash
7,593,774
5,578,513
5,749,123
Long term investments
1,175,266
1,238,234
1,239,664
Excess cash
8,040,738
6,185,388
6,451,451
Stockholders' equity
20,505,196
18,148,596
14,218,909
Invested Capital
17,926,258
16,005,826
12,237,248
ROIC
40.95%
35.55%
42.42%
ROCE
29.45%
25.65%
27.95%
EV
Common stock shares outstanding
409,809
407,532
409,757
Price
145.80
-12.41%
166.45
-38.67%
271.40
-39.54%
Market cap
59,750,099
-11.92%
67,833,679
-39.00%
111,208,087
-39.34%
EV
54,795,330
65,266,500
108,465,189
EBITDA
8,231,040
6,164,207
5,564,016
EV/EBITDA
6.66
10.59
19.49
Interest
38,130
43,745
33,690
Interest/NOPBT
0.50%
0.76%
0.64%